13D Filing: Scopia Capital and Acorda Therapeutics Inc (ACOR)

Page 10 of 10

Page 10 of 10 – SEC Filing


SCHEDULE A

TRANSACTIONS

The following table sets
forth all transactions by the Reporting Persons (on behalf of the Investment Vehicles) with respect to shares of Common Stock effected in the last 60 days, inclusive of any transactions effected through 4:00 p.m., New York City time, on
August 4, 2017. Except as otherwise noted below, all such transactions were purchases of Common Stock effected in the open market, and the table excludes commissions paid in per share prices.

Scopia Capital Management LP

Nature of Transaction

Shares of Common
Stock
Purchased/(Sold)
Price Per
Share ($)
Date of
Purchase / Sale

Purchase

70,000 $ 21.7001 7/24/2017

Purchase

14,621 $ 22.2294 7/24/2017

Purchase

50,000 $ 22.30 7/24/2017

Purchase

200,000 $ 22.8084 7/25/2017

Purchase

100,000 $ 22.8179 7/25/2017

Purchase

50,000 $ 23.0250 7/25/2017

Follow Acorda Therapeutics Inc. (NASDAQ:ACOR)

Page 10 of 10